Notice ID: cd23dd97753d48f287272ef81126f357Special Notice
Notice of Intent to Sole Source--POLYSERP�, a Non-FDA Approved Polyvalent F(ab')2 Immunoglobulin Fragments (Equine) Snake Antivenom
Archived. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 10:00 AM UTC−04:00
- Posted
- August 4, 2022
- Notice type
- Special Notice
- Agency
- Department of WarDepartment of the Army
Notice details
- Office
- W4PZ USA MED RSCH ACQUIS ACT
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- W81XWH22R0083
- Notice ID
- cd23dd97753d48f287272ef81126f357
Description
The United States Army Medical Research Acquisition Activity (USAMRAA) intends to issue a sole source contract under the authority of FAR 13.106(b)(1) Soliciting from a single source for purchases not exceeding the simplified acquisition threshold and only one source is reasonably available, on or about 19 August 2022 to CRO, LLC, 516 E. Spruce St., Missoula, MT 59802 under NAICS 325414 Biological Product (except Diagnostics) Manufacturing. The US Army Medical Materiel Development Activity (USAMMDA) Force Health Protection (FHP) Directorate has a requirement for: one (1) shipment of Polyvalent F(ab )2 Immunoglobulin Fragments (Equine), Snake Antivenom for multiple African nations. See attachment for details.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
W81XWH22R0083- 2×Special NoticeCurrentAug 3, 2022
Notice of Intent to Sole Source--POLYSERP�, a Non-FDA Approved Polyvalent F(ab')2 Immunoglobulin Fragments (Equine) Snake Antivenom
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
W81XWH22R0083
Archive Date
Not specified
Office Address
FORT DETRICK, MD, 21702-5014